71 filings
Page 2 of 4
6-K
ucgn85oo8hi808yjs39
14 Apr 23
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
4:05pm
6-K
lzxlsb
31 Mar 23
PolyPid Announces Proposed Underwritten Public Offering of Ordinary Shares
4:56pm
6-K
evjm16
31 Mar 23
Notice of ANNUAL and EXTRAORDINARY General Meeting of shareholders
4:49pm
6-K
yfnrx2 7hzu
10 Mar 23
Report of Foreign Private Issuer
2:00pm
6-K
ms398rd v8wicno9
21 Feb 23
Report of Foreign Private Issuer
4:01pm
6-K
w0i15 o34e8
8 Feb 23
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
7:15am
6-K
u4dh3vn7uo d51
24 Jan 23
PolyPid Provides Positive Regulatory Update for D-PLEX₁₀₀ for the Prevention of Surgical Site
7:05am
6-K
bqo2xv8qiau az
3 Jan 23
D-PLEX100 Achieved in Phase 2 Trial Significant Reduction in SSIs in Patients with Multiple Preoperative Risk Factors Versus Standard of Care
7:07am
6-K
xcwi ovuet3
12 Dec 22
Meeting Scheduled for January 2023
7:05am
6-K
f11 h3dc0k
9 Dec 22
PolyPid Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K
cexhr2cgfwwf7v54v
9 Nov 22
PolyPid Provides Corporate Update and Reports Third Quarter 2022 Financial Results
7:05am
6-K
gf8u4hjv6hmbenfqjtkt
20 Oct 22
PolyPid Announces Cost Reduction Plan
8:28am
6-K
e4chm6qcr9yu8ip4u
28 Sep 22
Report of Foreign Private Issuer
10:34am
6-K
nti7f7o4zobcw56y
2 Sep 22
PolyPid Announces Top-line Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
9:01am
6-K
q5u7cjx3yvr 123ua8l
10 Aug 22
Report of Foreign Private Issuer
4:07pm
6-K
pxf5r48te2
10 Aug 22
Report of Foreign Private Issuer
4:05pm
6-K
8fylky6m xd
10 Aug 22
PolyPid Provides Corporate Update and Reports Second Quarter 2022 Financial Results
12:00am
6-K
z1iva7x2hf21 mljg
8 Aug 22
Report of Foreign Private Issuer
4:02pm
6-K
4g0eeclu1r ry8k
3 Aug 22
PolyPid Announces Exclusive Licensing Agreement with ADVANZ PHARMA for the Commercialization of D-PLEX100 in Europe
7:07am
6-K
fuqt6tjep4qas ink4r
5 Jul 22
PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO
7:06am